Fredun Pharmaceuticals standalone net profit rises 39.72% in the March 2025 quarter

Sales rise 41.15% to Rs 165.44 crore

Net profit of Fredun Pharmaceuticals rose 39.72% to Rs 7.07 crore in the quarter ended March 2025 as against Rs 5.06 crore during the previous quarter ended March 2024. Sales rose 41.15% to Rs 165.44 crore in the quarter ended March 2025 as against Rs 117.21 crore during the previous quarter ended March 2024.

For the full year,net profit rose 33.23% to Rs 20.81 crore in the year ended March 2025 as against Rs 15.62 crore during the previous year ended March 2024. Sales rose 30.33% to Rs 451.71 crore in the year ended March 2025 as against Rs 346.58 crore during the previous year ended March 2024.

Particulars	Quarter Ended			Year Ended
	Mar. 2025	Mar. 2024	% Var.	Mar. 2025	Mar. 2024	% Var.
Sales	165.44	117.21	41	451.71	346.58	30
OPM %	10.54	9.53	-	12.20	11.22	-
PBDT	9.29	6.80	37	32.72	25.25	30
PBT	8.04	5.84	38	28.27	21.45	32
NP	7.07	5.06	40	20.81	15.62	33

Powered by Capital Market - Live News